{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T16:50:46Z","timestamp":1743007846438,"version":"3.40.3"},"publisher-location":"Cham","reference-count":107,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031213168"},{"type":"electronic","value":"9783031213175"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-21317-5_6","type":"book-chapter","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:03:40Z","timestamp":1679011420000},"page":"79-97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Revisiting the Biological and Clinical Impact of CDH1 Missense Variants"],"prefix":"10.1007","author":[{"given":"Joana","family":"Pereira","sequence":"first","affiliation":[]},{"given":"Soraia","family":"Melo","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"Maria Sofia","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Figueiredo","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Seruca","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"issue":"2","key":"6_CR1","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/S1470-2045(14)71016-2","volume":"16","author":"C Oliveira","year":"2015","unstructured":"Oliveira C et al (2015) Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol 16(2):e60\u2013e70","journal-title":"Lancet Oncol"},{"issue":"6674","key":"6_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/32918","volume":"392","author":"P Guilford","year":"1998","unstructured":"Guilford P et al (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392(6674):402\u2013405","journal-title":"Nature"},{"issue":"1","key":"6_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","volume":"1","author":"S Hansford","year":"2015","unstructured":"Hansford S et al (2015) Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol 1(1):23\u201332","journal-title":"JAMA Oncol"},{"issue":"8","key":"6_CR4","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S1470-2045(20)30219-9","volume":"21","author":"VR Blair","year":"2020","unstructured":"Blair VR et al (2020) Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol 21(8):e386\u2013e397","journal-title":"Lancet Oncol"},{"issue":"4","key":"6_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/jamasurg.2020.6155","volume":"156","author":"LA Gamble","year":"2021","unstructured":"Gamble LA, Heller T, Davis JL (2021) Hereditary diffuse gastric cancer syndrome and the role of CDH1 a review. JAMA Surg 156(4):387\u2013392","journal-title":"JAMA Surg"},{"issue":"6","key":"6_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","volume":"52","author":"RS van der Post","year":"2015","unstructured":"van der Post RS et al (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 52(6):361\u2013374","journal-title":"J Med Genet"},{"issue":"1","key":"6_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.giec.2021.08.009","volume":"32","author":"LA Gamble","year":"2022","unstructured":"Gamble LA, Davis JL (2022) Surveillance and surgical considerations in hereditary diffuse gastric cancer. Gastrointest Endosc Clin N Am 32(1):163\u2013175","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"12","key":"6_CR8","first-page":"873","volume":"36","author":"C Caldas","year":"1999","unstructured":"Caldas C et al (1999) Familial gastric cancer: overview and guidelines for management. J Med Genet 36(12):873\u2013880","journal-title":"J Med Genet"},{"issue":"4","key":"6_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/jmedgenet-2018-105807","volume":"56","author":"J Figueiredo","year":"2019","unstructured":"Figueiredo J et al (2019) Clinical spectrum and pleiotropic nature of CDH1 germline mutations. J Med Genet 56(4):199\u2013208","journal-title":"J Med Genet"},{"key":"6_CR10","doi-asserted-by":"crossref","unstructured":"Melo S et al (2017) Predicting the functional impact of CDH1 missense mutations in hereditary diffuse gastric cancer. Int J Mol Sci 18(12)","DOI":"10.3390\/ijms18122687"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2407-12-8","volume":"12","author":"G Corso","year":"2012","unstructured":"Corso G et al (2012) Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer 12:8","journal-title":"BMC Cancer"},{"issue":"5","key":"6_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/ncb3136","volume":"17","author":"T Lecuit","year":"2015","unstructured":"Lecuit T, Yap AS (2015) E-cadherin junctions as active mechanical integrators in tissue dynamics. Nat Cell Biol 17(5):533\u2013539","journal-title":"Nat Cell Biol"},{"issue":"23","key":"6_CR13","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","volume":"65","author":"F van Roy","year":"2008","unstructured":"van Roy F, Berx G (2008) The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65(23):3756\u20133788","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"6_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrm3112","volume":"12","author":"CC DuFort","year":"2011","unstructured":"DuFort CC, Paszek MJ, Weaver VM (2011) Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol 12(5):308\u2013319","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"6_CR15","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/s41467-017-01170-7","volume":"8","author":"M Rubsam","year":"2017","unstructured":"Rubsam M et al (2017) E-cadherin integrates mechanotransduction and EGFR signaling to control junctional tissue polarization and tight junction positioning. Nat Commun 8(1):1250","journal-title":"Nat Commun"},{"issue":"7","key":"6_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jmedgenet-2018-105337","volume":"55","author":"G Corso","year":"2018","unstructured":"Corso G et al (2018) Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect. J Med Genet 55(7):431\u2013441","journal-title":"J Med Genet"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/B978-0-12-394311-8.00015-7","volume":"116","author":"C Oliveira","year":"2013","unstructured":"Oliveira C et al (2013) E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci 116:337\u2013359","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"5","key":"6_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/gcc.22155","volume":"53","author":"V Molinaro","year":"2014","unstructured":"Molinaro V et al (2014) Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome. Genes Chromosomes Cancer 53(5):432\u2013445","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"6_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/jmg.2010.079814","volume":"48","author":"KA Schrader","year":"2011","unstructured":"Schrader KA et al (2011) Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. J Med Genet 48(1):64\u201368","journal-title":"J Med Genet"},{"issue":"5","key":"6_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/dds497","volume":"22","author":"IP Vogelaar","year":"2013","unstructured":"Vogelaar IP et al (2013) Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts. Hum Mol Genet 22(5):919\u2013926","journal-title":"Hum Mol Genet"},{"issue":"9","key":"6_CR21","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/gim.2017.11","volume":"19","author":"J Ghoumid","year":"2017","unstructured":"Ghoumid J et al (2017) Blepharocheilodontic syndrome is a CDH1 pathway-related disorder due to mutations in CDH1 and CTNND1. Genet Med 19(9):1013\u20131021","journal-title":"Genet Med"},{"issue":"2","key":"6_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41431-017-0010-5","volume":"26","author":"A Kievit","year":"2018","unstructured":"Kievit A et al (2018) Variants in members of the cadherin-catenin complex, CDH1 and CTNND1, cause blepharocheilodontic syndrome. Eur J Hum Genet 26(2):210\u2013219","journal-title":"Eur J Hum Genet"},{"key":"6_CR23","doi-asserted-by":"crossref","unstructured":"Corso G et al (2021) Geographical distribution of E-cadherin germline mutations in the context of diffuse gastric cancer: a systematic review. Cancers (Basel) 13(6)","DOI":"10.3390\/cancers13061269"},{"issue":"3","key":"6_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"6_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9","volume":"14","author":"PJ Guilford","year":"1999","unstructured":"Guilford PJ et al (1999) E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 14(3):249\u2013255","journal-title":"Hum Mutat"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.seminoncol.2022.03.001","volume":"49","author":"G Corso","year":"2022","unstructured":"Corso G et al (2022) Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations. Semin Oncol 49:130","journal-title":"Semin Oncol"},{"key":"6_CR27","doi-asserted-by":"crossref","unstructured":"Corso G et al (2020) Hereditary gastric and breast cancer syndromes related to CDH1 germline mutation: a multidisciplinary clinical review. Cancers (Basel) 12(6)","DOI":"10.3390\/cancers12061598"},{"issue":"5","key":"6_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/CEJ.0000000000000594","volume":"29","author":"C Santucci","year":"2020","unstructured":"Santucci C et al (2020) Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev 29(5):367\u2013381","journal-title":"Eur J Cancer Prev"},{"issue":"11","key":"6_CR29","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/humu.23650","volume":"39","author":"K Lee","year":"2018","unstructured":"Lee K et al (2018) Specifications of the ACMG\/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants. Hum Mutat 39(11):1553\u20131568","journal-title":"Hum Mutat"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-94-007-6570-2_7","volume":"7","author":"J Figueiredo","year":"2013","unstructured":"Figueiredo J, Seruca J (2013) Germline missense mutants in hereditary diffuse gastric cancer. Spotlight Familial Hereditary Gastric Cancer 7:77\u201386","journal-title":"Spotlight Familial Hereditary Gastric Cancer"},{"issue":"12","key":"6_CR31","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00109-006-0091-z","volume":"84","author":"G Suriano","year":"2006","unstructured":"Suriano G et al (2006) A model to infer the pathogenic significance of CDH1 germline missense variants. J Mol Med 84(12):1023\u20131031","journal-title":"J Mol Med"},{"issue":"6","key":"6_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/gut.2003.022061","volume":"53","author":"RC Fitzgerald","year":"2004","unstructured":"Fitzgerald RC, Caldas C (2004) Clinical implications of E-cadherin associated hereditary diffuse gastric cancer. Gut 53(6):775\u2013778","journal-title":"Gut"},{"key":"6_CR33","doi-asserted-by":"crossref","unstructured":"Figueiredo J et al (2021) Germline CDH1 G212E missense variant: combining clinical. In vitro and in vivo strategies to unravel disease burden. Cancers (Basel) 13(17)","DOI":"10.3390\/cancers13174359"},{"issue":"9","key":"6_CR34","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s41431-018-0173-8","volume":"26","author":"L Pena-Couso","year":"2018","unstructured":"Pena-Couso L et al (2018) Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer. Eur J Hum Genet 26(9):1348\u20131353","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"6_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrg3118","volume":"13","author":"G Gibson","year":"2012","unstructured":"Gibson G (2012) Rare and common variants: twenty arguments. Nat Rev Genet 13(2):135\u2013145","journal-title":"Nat Rev Genet"},{"issue":"5","key":"6_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424","journal-title":"Genet Med"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mrfmmm.2014.10.001","volume":"770","author":"L Zhang","year":"2014","unstructured":"Zhang L et al (2014) The germline CDH1 c.48 G>C substitution contributes to cancer predisposition through generation of a pro-invasive mutation. Mutat Res 770:106\u2013111","journal-title":"Mutat Res"},{"issue":"3","key":"6_CR38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/path.2415","volume":"216","author":"ME Barber","year":"2008","unstructured":"Barber ME et al (2008) Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J Pathol 216(3):286\u2013294","journal-title":"J Pathol"},{"issue":"3","key":"6_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033783","volume":"7","author":"J Simoes-Correia","year":"2012","unstructured":"Simoes-Correia J et al (2012) E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer. PLoS One 7(3):e33783","journal-title":"PLoS One"},{"issue":"7","key":"6_CR40","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073\u20131081","journal-title":"Nat Protoc"},{"issue":"4","key":"6_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248\u2013249","journal-title":"Nat Methods"},{"issue":"10","key":"6_CR42","doi-asserted-by":"publisher","first-page":"e46688","DOI":"10.1371\/journal.pone.0046688","volume":"7","author":"Y Choi","year":"2012","unstructured":"Choi Y et al (2012) Predicting the functional effect of amino acid substitutions and indels. PLoS One 7(10):e46688\u2013e46688","journal-title":"PLoS One"},{"issue":"4","key":"6_CR43","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0022-2836(02)00813-6","volume":"322","author":"CT Saunders","year":"2002","unstructured":"Saunders CT, Baker D (2002) Evaluation of structural and evolutionary contributions to deleterious mutation prediction. J Mol Biol 322(4):891\u2013901","journal-title":"J Mol Biol"},{"issue":"Web Server issu","key":"6_CR44","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz J et al (2005) The FoldX web server: an online force field. Nucleic Acids Res 33(Web Server issue):W382\u2013W388","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-2836(91)90380-O","volume":"220","author":"S Brunak","year":"1991","unstructured":"Brunak S, Engelbrecht J, Knudsen S (1991) Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol 220(1):49\u201365","journal-title":"J Mol Biol"},{"issue":"17","key":"6_CR46","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/nar\/24.17.3439","volume":"24","author":"SM Hebsgaard","year":"1996","unstructured":"Hebsgaard SM et al (1996) Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res 24(17):3439\u20133452","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"6_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/hmg\/ddg048","volume":"12","author":"G Suriano","year":"2003","unstructured":"Suriano G et al (2003) Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet 12(5):575\u2013582","journal-title":"Hum Mol Genet"},{"issue":"3","key":"6_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ejhg.2012.159","volume":"21","author":"J Figueiredo","year":"2013","unstructured":"Figueiredo J et al (2013) The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur J Hum Genet 21(3):301\u2013309","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"6_CR49","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/ejhg.2014.240","volume":"23","author":"JM Sanches","year":"2015","unstructured":"Sanches JM et al (2015) Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants. Eur J Hum Genet 23(8):1072\u20131079","journal-title":"Eur J Hum Genet"},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"25101","DOI":"10.1038\/srep25101","volume":"6","author":"T Mestre","year":"2016","unstructured":"Mestre T et al (2016) Quantification of topological features in cell meshes to explore E-cadherin dysfunction. Sci Rep 6:25101","journal-title":"Sci Rep"},{"issue":"1","key":"6_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-018-0859-0","volume":"17","author":"J Figueiredo","year":"2018","unstructured":"Figueiredo J et al (2018) E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancer. Mol Cancer 17(1):112","journal-title":"Mol Cancer"},{"issue":"22","key":"6_CR52","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1093\/hmg\/ddn249","volume":"17","author":"J Simoes-Correia","year":"2008","unstructured":"Simoes-Correia J et al (2008) Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer. Hum Mol Genet 17(22):3566\u20133576","journal-title":"Hum Mol Genet"},{"issue":"13","key":"6_CR53","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/onc.2015.225","volume":"35","author":"S Carvalho","year":"2016","unstructured":"Carvalho S et al (2016) Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer. Oncogene 35(13):1619\u20131631","journal-title":"Oncogene"},{"issue":"1","key":"6_CR54","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1038\/s41598-018-28570-z","volume":"8","author":"J Figueiredo","year":"2018","unstructured":"Figueiredo J et al (2018) Geometric compensation applied to image analysis of cell populations with morphological variability: a new role for a classical concept. Sci Rep 8(1):10266","journal-title":"Sci Rep"},{"issue":"22","key":"6_CR55","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1093\/hmg\/ddg316","volume":"12","author":"G Suriano","year":"2003","unstructured":"Suriano G et al (2003) E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet 12(22):3007\u20133016","journal-title":"Hum Mol Genet"},{"key":"6_CR56","first-page":"33","volume":"58","author":"T Boterberg","year":"2001","unstructured":"Boterberg T et al (2001) Cell aggregation assays. Methods Mol Med 58:33\u201345","journal-title":"Methods Mol Med"},{"key":"6_CR57","doi-asserted-by":"crossref","unstructured":"Kluijt I et al (2011) CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling. Int J Cancer","DOI":"10.1002\/ijc.26398"},{"issue":"5","key":"6_CR58","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.semcancer.2005.05.004","volume":"15","author":"HK Kleinman","year":"2005","unstructured":"Kleinman HK, Martin GR (2005) Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15(5):378\u2013386","journal-title":"Semin Cancer Biol"},{"issue":"24","key":"6_CR59","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1021\/bi00267a025","volume":"21","author":"HK Kleinman","year":"1982","unstructured":"Kleinman HK et al (1982) Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21(24):6188\u20136193","journal-title":"Biochemistry"},{"issue":"5","key":"6_CR60","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1158\/0008-5472.CAN-08-2457","volume":"69","author":"B Humar","year":"2009","unstructured":"Humar B et al (2009) E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res 69(5):2050\u20132056","journal-title":"Cancer Res"},{"issue":"5","key":"6_CR61","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1349-7006.2011.01890.x","volume":"102","author":"A Mimata","year":"2011","unstructured":"Mimata A et al (2011) Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci 102(5):942\u2013950","journal-title":"Cancer Sci"},{"issue":"3","key":"6_CR62","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/gutjnl-2011-300050","volume":"61","author":"S Shimada","year":"2012","unstructured":"Shimada S et al (2012) Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Gut 61(3):344\u2013353","journal-title":"Gut"},{"issue":"8\u201310","key":"6_CR63","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1387\/ijdb.072277jc","volume":"53","author":"J Caldeira","year":"2009","unstructured":"Caldeira J et al (2009) Using fruitflies to help understand the molecular mechanisms of human hereditary diffuse gastric cancer. Int J Dev Biol 53(8\u201310):1557\u20131561","journal-title":"Int J Dev Biol"},{"issue":"10","key":"6_CR64","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/hmg\/ddl093","volume":"15","author":"PS Pereira","year":"2006","unstructured":"Pereira PS et al (2006) E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and notch pathways in Drosophila epithelia. Hum Mol Genet 15(10):1704\u20131712","journal-title":"Hum Mol Genet"},{"issue":"1","key":"6_CR65","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s10120-021-01239-9","volume":"25","author":"J Figueiredo","year":"2022","unstructured":"Figueiredo J et al (2022) Integrin beta1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells. Gastric Cancer 25(1):124\u2013137","journal-title":"Gastric Cancer"},{"issue":"20","key":"6_CR66","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1093\/hmg\/ddv312","volume":"24","author":"J Caldeira","year":"2015","unstructured":"Caldeira J et al (2015) E-cadherin-defective gastric cancer cells depend on laminin to survive and invade. Hum Mol Genet 24(20):5891\u20135900","journal-title":"Hum Mol Genet"},{"issue":"8","key":"6_CR67","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1093\/hmg\/ddt602","volume":"23","author":"J Simoes-Correia","year":"2014","unstructured":"Simoes-Correia J et al (2014) DNAJB4 molecular chaperone distinguishes WT from mutant E-cadherin, determining their fate in vitro and in vivo. Hum Mol Genet 23(8):2094\u20132105","journal-title":"Hum Mol Genet"},{"issue":"8","key":"6_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023188","volume":"6","author":"J Figueiredo","year":"2011","unstructured":"Figueiredo J et al (2011) ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones. PLoS One 6(8):e23188","journal-title":"PLoS One"},{"issue":"6","key":"6_CR69","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00018-010-0595-0","volume":"68","author":"SS Pinho","year":"2011","unstructured":"Pinho SS et al (2011) Modulation of E-cadherin function and dysfunction by N-glycosylation. Cell Mol Life Sci 68(6):1011\u20131020","journal-title":"Cell Mol Life Sci"},{"issue":"13","key":"6_CR70","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/hmg\/ddm113","volume":"16","author":"AR Mateus","year":"2007","unstructured":"Mateus AR et al (2007) EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells. Hum Mol Genet 16(13):1639\u20131647","journal-title":"Hum Mol Genet"},{"issue":"8","key":"6_CR71","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.yexcr.2009.02.020","volume":"315","author":"AR Mateus","year":"2009","unstructured":"Mateus AR et al (2009) E-cadherin mutations and cell motility: a genotype-phenotype correlation. Exp Cell Res 315(8):1393\u20131402","journal-title":"Exp Cell Res"},{"issue":"1","key":"6_CR72","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.yexcr.2005.07.010","volume":"310","author":"P Ferreira","year":"2005","unstructured":"Ferreira P et al (2005) Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro. Exp Cell Res 310(1):99\u2013104","journal-title":"Exp Cell Res"},{"issue":"2","key":"6_CR73","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/hmg\/ddr469","volume":"21","author":"AC Ferreira","year":"2012","unstructured":"Ferreira AC et al (2012) E-cadherin impairment increases cell survival through notch-dependent upregulation of Bcl-2. Hum Mol Genet 21(2):334\u2013343","journal-title":"Hum Mol Genet"},{"issue":"1","key":"6_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-009-0531-x","volume":"13","author":"P Guilford","year":"2010","unstructured":"Guilford P, Humar B, Blair V (2010) Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer 13(1):1\u201310","journal-title":"Gastric Cancer"},{"issue":"15","key":"6_CR75","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1158\/1078-0432.CCR-05-0247","volume":"11","author":"G Suriano","year":"2005","unstructured":"Suriano G et al (2005) Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 11(15):5401\u20135409","journal-title":"Clin Cancer Res"},{"issue":"6","key":"6_CR76","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/carcin\/20.6.1127","volume":"20","author":"K Shinmura","year":"1999","unstructured":"Shinmura K et al (1999) Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 20(6):1127\u20131131","journal-title":"Carcinogenesis"},{"issue":"5","key":"6_CR77","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s10120-019-00945-9","volume":"22","author":"RSC Guindalini","year":"2019","unstructured":"Guindalini RSC et al (2019) Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil. Gastric Cancer 22(5):920\u2013931","journal-title":"Gastric Cancer"},{"issue":"2","key":"6_CR78","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/humu.9473","volume":"28","author":"H More","year":"2007","unstructured":"More H et al (2007) Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat 28(2):203","journal-title":"Hum Mutat"},{"issue":"1","key":"6_CR79","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/jmg.38.1.49","volume":"38","author":"E Avizienyte","year":"2001","unstructured":"Avizienyte E et al (2001) E-cadherin is not frequently mutated in hereditary gastric cancer. J Med Genet 38(1):49\u201352","journal-title":"J Med Genet"},{"issue":"4","key":"6_CR80","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ejca.2010.10.011","volume":"47","author":"G Corso","year":"2011","unstructured":"Corso G et al (2011) E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer 47(4):631\u2013639","journal-title":"Eur J Cancer"},{"issue":"21","key":"6_CR81","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1091\/mbc.E16-01-0058","volume":"27","author":"YI Petrova","year":"2016","unstructured":"Petrova YI, Schecterson L, Gumbiner BM (2016) Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell 27(21):3233\u20133244","journal-title":"Mol Biol Cell"},{"issue":"21","key":"6_CR82","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1001\/jama.297.21.2360","volume":"297","author":"P Kaurah","year":"2007","unstructured":"Kaurah P et al (2007) Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 297(21):2360\u20132372","journal-title":"JAMA"},{"issue":"3","key":"6_CR83","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10689-012-9595-6","volume":"12","author":"S Kim","year":"2013","unstructured":"Kim S et al (2013) Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients. Familial Cancer 12(3):503\u2013507","journal-title":"Familial Cancer"},{"issue":"3","key":"6_CR84","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s100380050137","volume":"44","author":"KA Yoon","year":"1999","unstructured":"Yoon KA et al (1999) Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 44(3):177\u2013180","journal-title":"J Hum Genet"},{"issue":"11","key":"6_CR85","first-page":"3465","volume":"7","author":"T Ikonen","year":"2001","unstructured":"Ikonen T et al (2001) Association of E-cadherin germ-line alterations with prostate cancer. Clin Cancer Res 7(11):3465\u20133471","journal-title":"Clin Cancer Res"},{"issue":"7","key":"6_CR86","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/jmg.2004.018275","volume":"41","author":"AR Brooks-Wilson","year":"2004","unstructured":"Brooks-Wilson AR et al (2004) Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 41(7):508\u2013517","journal-title":"J Med Genet"},{"issue":"7","key":"6_CR87","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.dld.2017.04.006","volume":"49","author":"M Betes","year":"2017","unstructured":"Betes M et al (2017) A multidisciplinary approach allows identification of a new pathogenic CDH1 germline missense mutation in a hereditary diffuse gastric cancer family. Dig Liver Dis 49(7):825\u2013826","journal-title":"Dig Liver Dis"},{"issue":"5","key":"6_CR88","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/humu.10068","volume":"19","author":"C Oliveira","year":"2002","unstructured":"Oliveira C et al (2002) Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 19(5):510\u2013517","journal-title":"Hum Mutat"},{"issue":"9","key":"6_CR89","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ejso.2007.03.001","volume":"33","author":"G Corso","year":"2007","unstructured":"Corso G et al (2007) Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. Eur J Surg Oncol 33(9):1061\u20131067","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"6_CR90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/jjco\/hyg002","volume":"33","author":"Y Wang","year":"2003","unstructured":"Wang Y et al (2003) Ile-Leu substitution (I415L) in germline E-cadherin gene (CDH1) in Japanese familial gastric cancer. Jpn J Clin Oncol 33(1):17\u201320","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"6_CR91","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2003.015594","volume":"41","author":"G Keller","year":"2004","unstructured":"Keller G et al (2004) Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet 41(6):e89","journal-title":"J Med Genet"},{"issue":"10","key":"6_CR92","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/modpathol.3880416","volume":"14","author":"JJ Ascano","year":"2001","unstructured":"Ascano JJ et al (2001) Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol 14(10):942\u2013949","journal-title":"Mod Pathol"},{"issue":"5","key":"6_CR93","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41416-021-01673-7","volume":"126","author":"E Adib","year":"2022","unstructured":"Adib E et al (2022) CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. Br J Cancer 126(5):797\u2013803","journal-title":"Br J Cancer"},{"issue":"6","key":"6_CR94","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3748\/wjg.v19.i6.909","volume":"19","author":"QH Chen","year":"2013","unstructured":"Chen QH et al (2013) Novel CDH1 germline mutations identified in Chinese gastric cancer patients. World J Gastroenterol 19(6):909\u2013916","journal-title":"World J Gastroenterol"},{"issue":"2","key":"6_CR95","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10238-012-0184-7","volume":"13","author":"M Garziera","year":"2013","unstructured":"Garziera M et al (2013) A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy. Clin Exp Med 13(2):149\u2013157","journal-title":"Clin Exp Med"},{"issue":"10","key":"6_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077035","volume":"8","author":"M Garziera","year":"2013","unstructured":"Garziera M et al (2013) Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer. PLoS One 8(10):e77035","journal-title":"PLoS One"},{"issue":"2","key":"6_CR97","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ijc.11197","volume":"106","author":"D Sarrio","year":"2003","unstructured":"Sarrio D et al (2003) Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 106(2):208\u2013215","journal-title":"Int J Cancer"},{"issue":"1","key":"6_CR98","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00404-017-4551-1","volume":"297","author":"F Stuebs","year":"2018","unstructured":"Stuebs F et al (2018) CDH1 mutation screen in a BRCA1\/2-negative familial breast-\/ovarian cancer cohort. Arch Gynecol Obstet 297(1):147\u2013152","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"6_CR99","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/gut.47.2.262","volume":"47","author":"HC Kim","year":"2000","unstructured":"Kim HC et al (2000) The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Gut 47(2):262\u2013267","journal-title":"Gut"},{"issue":"4","key":"6_CR100","first-page":"439","volume":"8","author":"S Salahshor","year":"2001","unstructured":"Salahshor S et al (2001) A germline E-cadherin mutation in a family with gastric and colon cancer. Int J Mol Med 8(4):439\u2013443","journal-title":"Int J Mol Med"},{"issue":"6","key":"6_CR101","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/ijc.10258","volume":"98","author":"BA Jonsson","year":"2002","unstructured":"Jonsson BA et al (2002) Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. Int J Cancer 98(6):838\u2013843","journal-title":"Int J Cancer"},{"issue":"1","key":"6_CR102","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00401-021-02307-1","volume":"142","author":"A Forster","year":"2021","unstructured":"Forster A et al (2021) Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin. Acta Neuropathol 142(1):191\u2013210","journal-title":"Acta Neuropathol"},{"issue":"11","key":"6_CR103","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1089\/gtmb.2019.0092","volume":"23","author":"S Du","year":"2019","unstructured":"Du S et al (2019) A novel CDH1 mutation causing reduced E-cadherin dimerization is associated with nonsyndromic cleft lip with or without cleft palate. Genet Test Mol Biomarkers 23(11):759\u2013765","journal-title":"Genet Test Mol Biomarkers"},{"issue":"6","key":"6_CR104","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.ajhg.2018.04.009","volume":"102","author":"LL Cox","year":"2018","unstructured":"Cox LL et al (2018) Mutations in the epithelial cadherin-p120-catenin complex cause Mendelian non-syndromic cleft lip with or without cleft palate. Am J Hum Genet 102(6):1143\u20131157","journal-title":"Am J Hum Genet"},{"issue":"11","key":"6_CR105","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/humu.22827","volume":"36","author":"LA Brito","year":"2015","unstructured":"Brito LA et al (2015) Rare variants in the epithelial cadherin gene underlying the genetic etiology of nonsyndromic cleft lip with or without cleft palate. Hum Mutat 36(11):1029\u20131033","journal-title":"Hum Mutat"},{"issue":"7","key":"6_CR106","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1089\/gtmb.2015.0325","volume":"20","author":"R Ittiwut","year":"2016","unstructured":"Ittiwut R et al (2016) Variants of the CDH1 (E-cadherin) gene associated with oral clefts in the Thai population. Genet Test Mol Biomarkers 20(7):406\u2013409","journal-title":"Genet Test Mol Biomarkers"},{"issue":"11","key":"6_CR107","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1002\/ajmg.a.37826","volume":"170","author":"E Nishi","year":"2016","unstructured":"Nishi E et al (2016) Exome sequencing-based identification of mutations in non-syndromic genes among individuals with apparently syndromic features. Am J Med Genet A 170(11):2889\u20132894","journal-title":"Am J Med Genet A"}],"container-title":["Hereditary Gastric and Breast Cancer Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-21317-5_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:04:30Z","timestamp":1679011470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-21317-5_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031213168","9783031213175"],"references-count":107,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-21317-5_6","relation":{},"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"17 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}